Hypoxia‐inducible factor‐2α directly promotes <i><scp>BCRP</scp></i> expression and mediates the resistance of ovarian cancer stem cells to adriamycin
Miao He(Shenyang Center for Disease Control and Prevention), Minjie Wei(Shenyang Center for Disease Control and Prevention)
Cited by 58
Related Papers
HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways
|Journal of Experimental & Clinical Cancer Research|2018|156
Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2′-O-methylation via NOP58 recruitment in colorectal cancer
|Molecular Cancer|2020|154
A novel HIF-2α targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI/GPR78-UPRER axis
|Cell Death and Differentiation|2022|92
Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer
|Journal for ImmunoTherapy of Cancer|2023|76
SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway
|Journal of Translational Medicine|2019|72